We are live on ! Find out more
VCG

Vantage Consulting Group Portfolio holdings

AUM $19.7M
1-Year Est. Return 280.87%
This Fund
S&P 500
This Quarter Est. Return
+17.65%
1 Year Est. Return
+280.87%
3 Year Est. Return
+261.08%
5 Year Est. Return
+180.34%
10 Year Est. Return
–
AUM
$1.23B
AUM Growth
–
Cap. Flow
+$1.06B
Cap. Flow %
86.51%
Top 10 Hldgs %
94.5%
Holding
1,884
New
1,883
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
RPRX icon
Royalty Pharma
RPRX
+$911M
2
ADCT icon
ADC Therapeutics
ADCT
+$55.1M
3
KYNB
Kyntra Bio
KYNB
+$25.5M
4
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$5.96M
5
KR icon
Kroger
KR
+$366K

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 95.04%
2 Technology 0.89%
3 Consumer Discretionary 0.79%
4 Industrials 0.61%
5 Consumer Staples 0.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MRNA icon
1776
Moderna
MRNA
$21.8B
$1K ﹤0.01%
+6
New +$607
MSGS icon
1777
Madison Square Garden
MSGS
$9.48B
$1K ﹤0.01%
+4
New +$658
MTN icon
1778
Vail Resorts
MTN
$5.32B
$1K ﹤0.01%
+2
New +$517
NBIX icon
1779
Neurocrine Biosciences
NBIX
$16.8B
$1K ﹤0.01%
+9
New +$869
NCNO icon
1780
nCino
NCNO
$2.02B
$1K ﹤0.01%
+15
New +$1.16K
NLY icon
1781
Annaly Capital Management
NLY
$17.1B
$1K ﹤0.01%
+35
New +$1.08K
NXST icon
1782
Nexstar Media Group
NXST
$5.82B
$1K ﹤0.01%
+9
New +$879
OKTA icon
1783
Okta
OKTA
$24.7B
$1K ﹤0.01%
+3
New +$713
OMF icon
1784
OneMain Financial
OMF
$7.2B
$1K ﹤0.01%
+31
New +$1.22K
PAG icon
1785
Penske Automotive Group
PAG
$14.3B
$1K ﹤0.01%
+17
New +$958
PANW icon
1786
Palo Alto Networks
PANW
$270B
$1K ﹤0.01%
+12
New +$561
PCG icon
1787
PG&E
PCG
$38.3B
$1K ﹤0.01%
+93
New +$1.05K
PEGA icon
1788
Pegasystems
PEGA
$5.02B
$1K ﹤0.01%
+10
New +$638
PODD icon
1789
Insulet
PODD
$11.5B
$1K ﹤0.01%
+5
New +$1.24K
RIO icon
1790
Rio Tinto
RIO
$158B
$1K ﹤0.01%
+17
New +$1.12K
RITM icon
1791
Rithm Capital
RITM
$5.52B
$1K ﹤0.01%
+119
New +$1.05K
RNG icon
1792
RingCentral
RNG
$4.66B
$1K ﹤0.01%
+3
New +$933
SAGE
1793
DELISTED
Sage Therapeutics
SAGE
$1K ﹤0.01%
+12
New +$884
SIRI icon
1794
SiriusXM
SIRI
$9.98B
$1K ﹤0.01%
+15
New +$921
SNDR icon
1795
Schneider National
SNDR
$6.26B
$1K ﹤0.01%
+42
New +$939
SPHR icon
1796
Sphere Entertainment
SPHR
$5.14B
$1K ﹤0.01%
+8
New +$611
SRPT icon
1797
Sarepta Therapeutics
SRPT
$1.57B
$1K ﹤0.01%
+6
New +$889
SSNC icon
1798
SS&C Technologies
SSNC
$18.1B
$1K ﹤0.01%
+15
New +$1K
ST icon
1799
Sensata Technologies
ST
$6.74B
$1K ﹤0.01%
+10
New +$481
STNE icon
1800
StoneCo
STNE
$2.77B
$1K ﹤0.01%
+8
New +$536
70 71
72
73 74

Similar funds

MVG
Madrona Venture Group Seattle, Washington $22.1M AUM 86.9% 1-Year Est. Return
NCM
Northwest Capital Management Lake Oswego, Oregon $23.1M AUM 13.6% 1-Year Est. Return
FFGIM
Founders Fund Growth II Management San Francisco, California $23.7M AUM
PIM
Profit Investment Management North Bethesda, Maryland $24.7M AUM 21.29% 1-Year Est. Return
HFG
Harborfront Financial Group Ludington, Michigan $13.4M AUM
SWM
Stark Wealth Management Bethlehem, Pennsylvania $26.6M AUM 23.19% 1-Year Est. Return
ICM
Infini Capital Management Central, Hong Kong $12.4M AUM 53.5% 1-Year Est. Return
SM
Southport Management Wilson, Wyoming $28.6M AUM 41.61% 1-Year Est. Return

Vantage Consulting Group's Q4 2020 Portfolio in Review

Q4 2020 is the first quarter with a 13F filing on record for Vantage Consulting Group, which disclosed 1,884 positions worth $1.23B. Its ten largest holdings account for 94% of the portfolio.

Its largest position is Royalty Pharma: 21,477,282 shares worth $1.07B.

By sector, the portfolio is most concentrated in Healthcare at 95% of assets, followed by Technology and Consumer Discretionary.

  • Vantage Consulting Group's largest Q4 2020 buy was Royalty Pharma: 21,477,282 shares worth $1.07B.
  • Vantage Consulting Group's ten largest holdings make up 94% of its $1.23B portfolio in Q4 2020.
  • Vantage Consulting Group disclosed 1,884 positions in Q4 2020, its first 13F filing on record.

Based on Vantage Consulting Group's 13F filing for Q4 2020, filed 12 Feb 2021.